Nemolizumab Alternatives Compared
Nemolizumab | Dupixent (dupilumab) | Dupilumab |
|
---|
Nemolizumab | Dupixent (dupilumab) | Dupilumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Prurigo Nodularis, Atopic Dermatitis. Nemolizumab may also be used for purposes not listed in this medication guide. |
Prescription only
Dupixent injection is usually given every 1 to 4 weeks to treat asthma, eczema, chronic rhinosinusitis, COPD, eosinophilic esophagitis, chronic urticaria, prurigo nodularis, or bullous pemphigoid... View more |
Prescription only
Prescribed for Eosinophilic Esophagitis, Chronic Rhinosinusitis With Nasal Polyps, Prurigo Nodularis, Eczema, Atopic Dermatitis, Asthma, Asthma - Maintenance, Bullous Pemphigoid, COPD, Urticaria... View more |
Related suggestions Atopic Dermatitis
Prurigo Nodularis
|
|||||||
More about Nemolizumab | More about Dupixent (dupilumab) | More about Dupilumab | ||||||||
Ratings & Reviews | ||||||||||
Nemolizumab has an average rating of 10.0 out of 10 from a total of 4 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Dupixent has an average rating of 7.3 out of 10 from a total of 516 ratings on Drugs.com. 62% of reviewers reported a positive effect, while 19% reported a negative effect. |
Dupilumab has an average rating of 7.3 out of 10 from a total of 540 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Nemolizumab side effects |
View all Dupixent side effects |
View all Dupilumab side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Dupixent prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Nemluvio |
N/A |
Dupixent | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
453.6 hours |
N/A |
N/A |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 151 drugs are known to interact with Nemolizumab:
|
A total of 97 drugs are known to interact with Dupixent:
|
A total of 97 drugs are known to interact with Dupilumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
March 28, 2017 |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.